Acadia Healthcare Company, Inc.
NASDAQ:ACHCMedical - Care Facilities
+$1.14 today
- Market cap
- $3.49B
- Beta
- 0.69
- P/E (TTM)
- -2.0
- EPS (TTM)
- -$12.23
Volume 1.52M
Average 2.82M
ACHC Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Acadia Healthcare Company, Inc.NASDAQ: ACHC
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization grows in line with its trailing trend
Q3 FY2026 depreciation & amortization of $53.13M rose 11.9% year over year, ahead of the +10.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 5.4% from the prior quarter. Over 3 fiscal years it compounded at +17.1% a year.
Context
- Depreciation & amortization amounted to 5.7% of revenue in FY2025, up 1.0 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +11.9% holds above the trailing-twelve-month pace of +10.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 189.25M USD
- Year-over-year change
- +26.5%
- 4-year CAGR
- +15.4%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 189.25M | +26.5% |
| FY2024 | 2024-12-31 | 149.6M | +13.0% |
| FY2023 | 2023-12-31 | 132.35M | +12.4% |
| FY2022 | 2022-12-31 | 117.77M | +10.4% |
| FY2021 | 2021-12-31 | 106.72M | — |
Depreciation & Amortization vs competitors
How ACHC compares with its peers on the latest reported figures
- ACHC's LTM Sep 2026 depreciation & amortization of $201.74M is the 2nd largest of the 3 companies compared; the peer median is $347.86M.
- Its year-over-year change of +10.2% is the highest of 3, against a peer median of +1.1%.
- Depreciation & amortization amounts to 5.9% of revenue for ACHC, versus a peer median of 3.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $641.16M | +7.5% | +2.1% | 3.5% | |
| LTM Sep 2026 | $201.74M | +10.2% | +17.1% | 5.9% | |
| LTM Jun 2026 | $54.56M | -5.2% | -7.5% | 3.4% | |
| Peer median (excluding ACHC) | $347.86M | +1.1% | -2.7% | 3.5% | |
Competitors are the stored peer set for ACHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 195.56M | 280.03M | (15.66M) | 264.48M | (1.09B) |
| Depreciation & Amortization | 106.72M | 117.77M | 132.35M | 149.6M | 189.25M |
| Deferred Income Tax | 11.77M | 16.55M | (93.98M) | 67.71M | 1.09M |
| Stock-Based Compensation | 37.53M | 29.64M | 32.29M | 37.11M | 31.71M |
| Change in Working Capital | (43.5M) | (69.35M) | 6.63M | (405.89M) | (8.67M) |
| Accounts Receivables | 2.45M | (41.98M) | (39.01M) | (2.33M) | (75.02M) |
| Inventory | (13.99M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 6.16M | 5.17M | 17.4M | (420.89M) | 14.88M |
| Other Working Capital | (38.13M) | (32.55M) | 28.24M | 17.34M | 51.48M |
| Other Non-Cash Items | 66.4M | 5.94M | 400.71M | 16.68M | 1.01B |
| Operating Cash Flow | 374.48M | 380.57M | 462.34M | 129.69M | 131.9M |
| Capital Expenditures | (244.81M) | (296.15M) | (424.13M) | (690.39M) | (571.81M) |
| Acquisitions (Net) | 1.37B | (9.51M) | (349K) | (53.55M) | 24.32M |
| Purchases of Investments | (84.8M) | 0 | 0 | 0 | 0 |
| Sales of Investments | 244.81M | 0 | 0 | 0 | 0 |
| Other Investing Activities | (269.58M) | (174K) | 27.26M | 7.46M | (90K) |
| Investing Cash Flow | 1.02B | (305.83M) | (397.22M) | (736.48M) | (547.58M) |
| Debt Repayment | (1.64B) | (113.59M) | (16.25M) | 583.67M | 532.34M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (5.73M) | 0 | (52.53M) | (8.55M) | (50.03M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 5.58M | 2.69M | 6.09M | 7.9M | (9.69M) |
| Financing Cash Flow | (1.64B) | (110.9M) | (62.7M) | 583.02M | 472.61M |
| Effect of Forex Changes | 4.07M | 0 | 0 | 0 | 0 |
| Net Change in Cash | (244.88M) | (36.16M) | 2.42M | (23.77M) | 56.94M |
| Free Cash Flow | 129.67M | 84.42M | 38.21M | (560.69M) | (439.91M) |
Acadia Healthcare Company, Inc.
NASDAQ:ACHC
Intrinsic Alpha fair value
Locked
Current Price
$37.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.